Cargando…

Comment on “Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis”

Detalles Bibliográficos
Autores principales:	Nevez, Gilles, Hoffmann, Claire, Le Gal, Solène
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615577/ https://www.ncbi.nlm.nih.gov/pubmed/37908307 http://dx.doi.org/10.1155/2023/9793264

Ejemplares similares

Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis
por: Sullivan, Abigayle, et al.
Publicado: (2020)

Possible Nosocomial Transmission of Pneumocystis jirovecii
por: Damiani, Céline, et al.
Publicado: (2012)

Pneumocystis jirovecii in Patients With Cystic Fibrosis: A Review
por: Bonnet, Pierre, et al.
Publicado: (2020)

Pneumocystis jirovecii Diversity in Réunion, an Overseas French Island in Indian Ocean
por: Le Gal, Solène, et al.
Publicado: (2020)

Hypothetical Pneumocystis jirovecii Transmission from Immunocompetent Carriers to Infant
por: Hauser, Philippe, et al.
Publicado: (2009)

Selection of Pneumocystis jirovecii Inosine 5′-Monophosphate Dehydrogenase Mutants in Solid Organ Transplant Recipients: Implication of Mycophenolic Acid
por: Hoffmann, Claire V., et al.
Publicado: (2021)

1024. Evaluation of Atovaquone Prescribing for Pneumocystis jiroveci Pneumonia (PJP) Prophylaxis
por: Aleissa, Muneerah, et al.
Publicado: (2019)

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
por: Atkinson, Andrew, et al.
Publicado: (2021)

Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/µL and Virologic Suppression: A Systematic Review
por: Costiniuk, Cecilia T., et al.
Publicado: (2011)

Nonadherence to Primary Prophylaxis against Pneumocystis jirovecii Pneumonia
por: Heffelfinger, James D., et al.
Publicado: (2009)

Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis
por: Dunbar, Albert, et al.
Publicado: (2020)

Pneumocystis jirovecii Pneumonia Prophylaxis for Cancer Patients during Chemotherapy
por: Takeuchi, Kazuto, et al.
Publicado: (2021)

The Impact of Absolute CD4 Count and Percentage Discordance on Pneumocystis Jirovecii Pneumonia Prophylaxis in HIV-Infected Patients
por: Anyimadu, Henry, et al.
Publicado: (2018)

Spelling Pneumocystis jirovecii
por: Stringer, James R., et al.
Publicado: (2009)

Etymologia: Pneumocystis jirovecii
por: Henry, Ronnie
Publicado: (2017)

Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
por: Mori, Shunsuke, et al.
Publicado: (2015)

Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis
por: Andreasen, Philip B., et al.
Publicado: (2021)

Pneumocystis jirovecii Pneumonia in Patients with or without AIDS, France
por: Roux, Antoine, et al.
Publicado: (2014)

Antibody Response to Pneumocystis jirovecii: Antibody Response to Pneumocystis jirovecii Major Surface Glycoprotein
por: Daly, Kieran R., et al.
Publicado: (2006)

Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study
por: Alanio, Alexandre, et al.
Publicado: (2017)

Pneumocystis jirovecii in General Population
por: Medrano, Francisco J., et al.
Publicado: (2005)

Inability to Culture Pneumocystis jirovecii
por: Liu, Yueqin, et al.
Publicado: (2018)

Transmission and Colonization of Pneumocystis jirovecii
por: Vera, Cristian, et al.
Publicado: (2021)

Low Titer Pneumocystis jirovecii Infections: More than Just Colonization?
por: Prickartz, Alexander, et al.
Publicado: (2016)

Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review
por: Sierra, Caroline M., et al.
Publicado: (2022)

Vertical Transmission of Pneumocystis jirovecii in Humans
por: Montes-Cano, Marco A., et al.
Publicado: (2009)

Pneumocystis jirovecii pneumonia in developing countries
por: De Armas Rodríguez, Y., et al.
Publicado: (2011)

Therapy and Management of Pneumocystis jirovecii Infection
por: White, P. Lewis, et al.
Publicado: (2018)

Colonisation with Pneumocystis jirovecii in Australian infants
por: Chua, Kyra Y.L., et al.
Publicado: (2015)

Humans Are Selectively Exposed to Pneumocystis jirovecii
por: Cissé, Ousmane H., et al.
Publicado: (2020)

Detection of Pneumocystis jirovecii in Hospitalized Children Less Than 3 Years of Age
por: Menu, Estelle, et al.
Publicado: (2021)

1487. Variability of Pneumocystis jirovecii Prophylaxis Use Among Pediatric Solid Organ Transplant Providers
por: Paulsen, Grant, et al.
Publicado: (2018)

Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients
por: Goto, Norihiko, et al.
Publicado: (2017)

2695. Pneumocystis jirovecii Pneumonia in the Era of Effective Prophylaxis Following Hematopoietic Stem Cell Transplant
por: Drelick, Alexander Christian, et al.
Publicado: (2019)

Pneumocystis jirovecii colonization in chronic pulmonary disease
por: Gutiérrez, S., et al.
Publicado: (2011)

Atypical radiographic manifestation in Pneumocystis jirovecii pneumonia
por: Yamakuchi, Hiroki
Publicado: (2017)

Pneumocystis jirovecii in Spanish Patients With Heart Failure
por: Merino-Casallo, Izarbe, et al.
Publicado: (2019)

Tension Pneumothorax Following Pneumocystis jirovecii Pneumonia
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)

Dexamethasone: Pneumocystis jirovecii pneumonia: case report
Publicado: (2022)

Upadacitinib: Pneumocystis jirovecii pneumonia: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qb478ikela5fkksec15cdm5jlc